Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy
by Bob Yirka , Medical XpressCredit: CC0 Public DomainA large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center has
Updated on: March 08,2024
10
Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy
by Bob Yirka , Medical XpressCredit: CC0 Public DomainA large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center has
Updated on:March 08,2024
10
